Showing results (391-400 of 458) with videos related to
Sort By:
Pageof 46
JACC. Advances|July 27, 2025
Long-Term Nonprogression Is a Form of Response to Cardiac Resynchronization TherapySander Trenson, Peter C Kahr, Bert Vandenberk, et al.ESC Heart Failure|January 21, 2022
Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosisEmanuel Zampiccoli, Jens Barthelmes, Leonie Kreysing, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|August 2, 2012
Normal vascular function as a prerequisite for the absence of coronary calcification in patients free of cardiovascular disease and diabetesJing Li, Andreas J Flammer, Rebecca E Nelson, et al.Heart (British Cardiac Society)|July 31, 2024
Prognostic value of plasma big endothelin-1 in patients with light chain cardiac amyloidosisZhongli Chen, Anteng Shi, Zhiyan Wang, et al.Transplantation|April 25, 2018
Long-term Outcomes of Kidney Transplantation in Fabry DiseaseSara Ersözlü, Robert J Desnick, Uyen Huynh-Do, et al.Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.European Heart Journal|January 25, 2013
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practiceJing Li, Muhamad Y Elrashidi, Andreas J Flammer, et al.Mayo Clinic Proceedings|September 18, 2012
Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular functionJing Li, Andreas J Flammer, Ryan J Lennon, et al.Journal of Hypertension|March 14, 2007
Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertensionAndreas J Flammer, Frank Hermann, Peter Wiesli, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 17, 2013
Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantationYoshiki Matsuo, Andrew Cassar, Satoshi Yoshino, et al.Pageof 46